BAT Tests Find Overfilled E-Cigarette Liquids in UK Market

Mar.17.2023
BAT Tests Find Overfilled E-Cigarette Liquids in UK Market
A test by BAT found most major disposable e-cigarette brands in the UK have overfilled e-liquid, according to betterRetailing.

On March 17th, UK media outlet betterRetailing released a report on BAT (British American Tobacco) testing, which revealed that almost all major disposable e-cigarette brands in the UK had exceeded the legal limit for nicotine content in their e-liquids. This included popular UK brands such as Elfbar, LOSTMARY, SMOK, SKE Crystal, and Solo. BAT sent the results of the testing report to distributors, retailers, and regulatory bodies, urging them to ensure that non-compliant products were not supplied.


The President of UKVIA, John...


In response to this incident, 2FIRSTS conducted an email interview with the President of the UK Vaping Industry Association (UKVIA), John. The original interview in English can be accessed by clicking the provided link. The following is the full transcript of the interview.


Can you provide the English translation of "Q:2FIRSTS"? It is unclear what you are referring to.


A spokesperson for the UK Vaping Industry Association (UKVIA), John


According to a report from Better Retailing, British American Tobacco conducted testing on disposable e-cigarette liquid in the UK market and sent the results to distributors and government departments. Has the association been made aware of this news? Did British American Tobacco send the testing report to the association?


BAT has conducted numerous tests on disposable e-cigarette brands in the UK and shared its findings with various organizations, including the association. It is also known that other companies have conducted similar tests, but their results differ from those of BAT.


Do you believe that the issue of "e-cigarette e-liquid exceeding standards" is a common problem in the UK e-cigarette market?


A: Yes, based on the data we have seen, we do believe that some brands have been using excessive amounts of e-liquid to gain a competitive advantage.


Question: Will this test result regarding the excessive levels found in disposable e-cigarettes have an impact on the disposable e-cigarette market in the UK?


A: Yes, I believe this highlights issues with the MHRA approval process. I expect this process to become more rigorous. Additionally, I think major distributors should now perform their own testing on products they bring in. Non-compliant behavior is unacceptable.


Several brand dealers have said that some of the products tested by BAT are "old inventory," while the latest products are now compliant with standards. Will UKVIA test the latest products?


A: The key issue is not the inventory itself, as "old stock" is not a legitimate excuse. In fact, it's quite simple - products are either compliant or non-compliant. I believe all brands should conduct regular testing to ensure they are following the rules. The association will not protect those who break the law.


Q: Has BAT been in contact with the association and asked them to take measures?


Yes, we have had multiple discussions with BAT regarding this issue. If the MHRA and trade transaction standards are the regulators and enforcers in this matter, we will work with both institutions to ensure that the products sold in the UK are legal. The association will also protect its good reputation.


Special Statement: The above content is a translated article, for accurate interpretation please refer to the original English version.


Click here to read the original article in English: UKVIA responds to overfill incident, alleging that BAT's findings contradict tests conducted by other companies.


Further reading:


Content summary of the ELFBAR over-the-limit e-liquid incident in the UK.


British media reports obtaining BAT test report: Almost all disposable e-cigarette brands in the UK have excessive e-liquid levels.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
Australia’s Victoria Steps Up Illegal Tobacco Enforcement With Store Closures and Penalties of Up to A$2.5 Million
Australia’s Victoria Steps Up Illegal Tobacco Enforcement With Store Closures and Penalties of Up to A$2.5 Million
Australia’s state of Victoria has activated new powers allowing Tobacco Licensing Victoria and police to shut premises suspected of selling, supplying or possessing illicit tobacco for up to 90 days. Longer closures can be ordered by a magistrates’ court. Businesses subject to closure orders must generally cease all trading and will be placed on a public list. Breaching a closure order can carry penalties of up to A$2.5 million and 20 years in prison.
Sep.10
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
U.S. technology and investigative publication WIRED has examined how nicotine analogs are emerging as a new challenge for the country’s vape regulatory framework. The article argues that after the U.S. expanded federal oversight of nicotine products in 2022, some manufacturers began using nicotine-like compounds such as 6-methyl-nicotine that may fall outside existing definitions. Researchers cited by WIRED said some nicotine analogs could be more potent than traditional nicotine, although human health impacts remain unclear. U.S. policymakers are considering broader definitions of nicotine to bring these compounds under federal oversight.
Jul.27
Nasdaq-Listed Vape Company iSpire Technology Restructures Leadership as Tuanfang Liu Becomes Sole CEO, BTIG Initiates Coverage on ODM Growth Opportunity
Nasdaq-Listed Vape Company iSpire Technology Restructures Leadership as Tuanfang Liu Becomes Sole CEO, BTIG Initiates Coverage on ODM Growth Opportunity
Nasdaq-listed vape company iSpire Technology has restructured its leadership team, with Tuanfang Liu becoming the company’s sole chief executive officer (CEO) and Michael Wang appointed CEO of Aspire North America. The move ends iSpire’s previous co-CEO structure and creates clearer responsibilities between group strategy and regional execution. Separately, BTIG initiated coverage on iSpire Technology with a Buy rating and a $3.50 price target, identifying ODM growth opportunities as a key investment factor.
Jul.27
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03